SIMILAR PATTERNS OF AMINO ACIDS FOR 3EYG_A_MI1A1_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k9a CARBOXYL-TERMINAL
SRC KINASE

(Rattus
norvegicus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		8 GLY A 207
VAL A 209
ALA A 220
LYS A 222
SER A 273
ASN A 319
LEU A 321
ASP A 332
 None
 0.70A 3eygA-1k9aA:
31.2		 3eygA-1k9aA:
26.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nxk MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  70
GLY A  71
GLY A  76
VAL A  78
ALA A  91
LYS A  93
MET A 138
ASN A 191
ASP A 207
 STU  A 401 (-3.9A)
STU  A 401 (-3.6A)
None
STU  A 401 (-4.7A)
STU  A 401 (-3.4A)
STU  A 401 ( 4.5A)
STU  A 401 (-3.2A)
STU  A 401 (-4.5A)
STU  A 401 (-3.6A)
 0.62A 3eygA-1nxkA:
21.6		 3eygA-1nxkA:
25.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1py5 TGF-BETA RECEPTOR
TYPE I

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		9 GLY A 212
GLY A 214
GLY A 217
VAL A 219
ALA A 230
LYS A 232
SER A 287
ASN A 338
LEU A 340
 None
None
None
PY1  A 700 ( 4.7A)
PY1  A 700 (-3.5A)
PY1  A 700 (-3.9A)
None
None
PY1  A 700 (-4.4A)
 0.70A 3eygA-1py5A:
28.0		 3eygA-1py5A:
26.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  78
GLY A  79
GLY A  81
GLY A  84
VAL A  86
ALA A  99
LYS A 101
MET A 147
LEU A 201
 ATP  A 535 (-3.9A)
ATP  A 535 ( 3.9A)
ATP  A 535 (-3.8A)
ATP  A 535 ( 4.4A)
ATP  A 535 (-4.1A)
ATP  A 535 (-3.6A)
ATP  A 535 ( 2.5A)
ATP  A 535 ( 3.4A)
ATP  A 535 (-4.8A)
 0.85A 3eygA-1s9iA:
15.5		 3eygA-1s9iA:
26.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 344
GLY A 345
VAL A 352
ALA A 367
MET A 414
ASN A 466
LEU A 468
ASP A 479
 STU  A 100 (-3.8A)
STU  A 100 (-3.3A)
STU  A 100 (-4.8A)
STU  A 100 (-3.2A)
STU  A 100 (-3.6A)
STU  A 100 (-4.2A)
STU  A 100 (-4.5A)
STU  A 100 (-3.5A)
 0.60A 3eygA-1u59A:
32.3		 3eygA-1u59A:
36.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u5q SERINE/THREONINE
PROTEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		8 GLY A  35
VAL A  42
ALA A  55
LYS A  57
MET A 105
SER A 111
ASN A 156
LEU A 158
 None
 0.69A 3eygA-1u5qA:
25.9		 3eygA-1u5qA:
25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  15
GLY A  16
GLY A  21
VAL A  23
ALA A  36
LYS A  38
ASN A 135
LEU A 137
ASP A 148
 HYM  A 400 (-4.2A)
HYM  A 400 ( 3.8A)
None
HYM  A 400 (-4.3A)
HYM  A 400 (-3.5A)
HYM  A 400 (-3.2A)
HYM  A 400 (-4.2A)
HYM  A 400 (-4.5A)
HYM  A 400 (-3.9A)
 0.68A 3eygA-1zltA:
25.2		 3eygA-1zltA:
27.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU X  17
GLY X  18
GLY X  20
VAL X  25
ALA X  37
LYS X  39
SER X  89
LEU X 137
ASP X 148
 STU  X 902 (-3.8A)
STU  X 902 ( 3.7A)
None
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-3.1A)
STU  X 902 ( 4.0A)
STU  X 902 (-4.4A)
STU  X 902 (-3.6A)
 0.86A 3eygA-2dq7X:
32.9		 3eygA-2dq7X:
34.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU X  17
GLY X  18
GLY X  20
VAL X  25
ALA X  37
SER X  89
ASN X 135
LEU X 137
ASP X 148
 STU  X 902 (-3.8A)
STU  X 902 ( 3.7A)
None
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 ( 4.0A)
STU  X 902 ( 4.9A)
STU  X 902 (-4.4A)
STU  X 902 (-3.6A)
 1.04A 3eygA-2dq7X:
32.9		 3eygA-2dq7X:
34.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU X  17
GLY X  18
VAL X  25
ALA X  37
LYS X  39
SER X  89
ASN X 135
LEU X 137
ASP X 148
 STU  X 902 (-3.8A)
STU  X 902 ( 3.7A)
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-3.1A)
STU  X 902 ( 4.0A)
STU  X 902 ( 4.9A)
STU  X 902 (-4.4A)
STU  X 902 (-3.6A)
 0.64A 3eygA-2dq7X:
32.9		 3eygA-2dq7X:
34.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		8 GLY A  35
VAL A  42
ALA A  55
MET A 105
SER A 111
ASN A 156
LEU A 158
ASP A 169
 STU  A 400 (-3.3A)
STU  A 400 ( 4.8A)
STU  A 400 (-3.2A)
STU  A 400 ( 3.7A)
STU  A 400 (-3.3A)
STU  A 400 (-4.4A)
STU  A 400 ( 4.6A)
STU  A 400 (-3.6A)
 0.65A 3eygA-2gcdA:
26.6		 3eygA-2gcdA:
29.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		9 LEU A 273
GLY A 274
GLY A 279
VAL A 281
ALA A 293
LYS A 295
SER A 345
ASN A 391
LEU A 393
 H8H  A 534 (-3.8A)
H8H  A 534 ( 3.8A)
None
H8H  A 534 (-4.4A)
H8H  A 534 (-3.2A)
H8H  A 534 (-3.7A)
H8H  A 534 ( 4.5A)
H8H  A 534 ( 4.9A)
H8H  A 534 (-4.5A)
 0.93A 3eygA-2h8hA:
28.8		 3eygA-2h8hA:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hck HEMATOPOETIC CELL
KINASE HCK

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		10 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
LYS A 295
SER A 345
ASN A 391
LEU A 393
 QUE  A   1 (-3.9A)
QUE  A   1 ( 4.2A)
None
None
QUE  A   1 ( 4.8A)
QUE  A   1 (-3.5A)
None
QUE  A   1 ( 4.7A)
None
QUE  A   1 (-4.4A)
 0.90A 3eygA-2hckA:
28.1		 3eygA-2hckA:
27.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 248
GLY A 249
GLY A 251
GLY A 254
VAL A 256
ALA A 269
LYS A 271
ASN A 368
LEU A 370
 GIN  A 600 ( 4.6A)
None
None
None
GIN  A 600 ( 4.7A)
GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
None
GIN  A 600 (-4.7A)
 0.55A 3eygA-2hz0A:
32.0		 3eygA-2hz0A:
36.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF00373
(FERM_M)
PF07714
(Pkinase_Tyr) 		8 GLY A 429
GLY A 431
GLY A 434
VAL A 436
ALA A 452
LYS A 454
MET A 499
LEU A 553
 4ST  A1687 (-3.1A)
None
None
4ST  A1687 ( 4.8A)
4ST  A1687 (-3.3A)
4ST  A1687 (-3.4A)
4ST  A1687 ( 3.9A)
4ST  A1687 (-4.4A)
 0.69A 3eygA-2j0jA:
30.6		 3eygA-2j0jA:
19.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 344
GLY A 345
GLY A 347
GLY A 350
VAL A 352
ALA A 367
LYS A 369
MET A 414
 ANP  A 615 (-4.4A)
ANP  A 615 ( 4.4A)
ANP  A 615 (-3.6A)
None
ANP  A 615 (-4.5A)
ANP  A 615 (-3.3A)
ANP  A 615 (-3.1A)
ANP  A 615 ( 3.9A)
 0.69A 3eygA-2ozoA:
26.7		 3eygA-2ozoA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qlu ACTIVIN RECEPTOR
TYPE IIB

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A 199
GLY A 202
VAL A 204
ALA A 215
LYS A 217
SER A 272
ASN A 326
LEU A 328
ASP A 339
 None
None
ADE  A 488 ( 4.9A)
ADE  A 488 (-3.2A)
None
None
None
ADE  A 488 (-4.4A)
None
 0.69A 3eygA-2qluA:
28.3		 3eygA-2qluA:
26.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r4b RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 724
GLY A 725
GLY A 730
VAL A 732
ALA A 749
LYS A 751
ASN A 848
LEU A 850
ASP A 861
 GW7  A   1 ( 4.2A)
None
None
GW7  A   1 ( 4.8A)
GW7  A   1 (-3.3A)
GW7  A   1 (-3.9A)
None
GW7  A   1 (-4.2A)
GW7  A   1 (-4.1A)
 0.72A 3eygA-2r4bA:
30.1		 3eygA-2r4bA:
36.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wtk SERINE/THREONINE-PRO
TEIN KINASE 11

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU C  55
GLY C  56
GLY C  58
GLY C  61
VAL C  63
ALA C  76
MET C 129
LEU C 183
 ANP  C   2 ( 4.4A)
ANP  C   2 (-3.3A)
ANP  C   2 (-3.0A)
ANP  C   2 (-3.8A)
ANP  C   2 (-4.2A)
ANP  C   2 (-3.4A)
None
None
 0.65A 3eygA-2wtkC:
25.0		 3eygA-2wtkC:
28.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xik SERINE/THREONINE
PROTEIN KINASE 25

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A  27
GLY A  32
VAL A  34
ALA A  47
LYS A  49
MET A  95
SER A 102
LEU A 147
 J60  A1294 ( 4.1A)
None
J60  A1294 ( 4.9A)
J60  A1294 (-3.3A)
None
J60  A1294 ( 3.8A)
None
J60  A1294 (-4.8A)
 0.71A 3eygA-2xikA:
20.9		 3eygA-2xikA:
32.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2xik SERINE/THREONINE
PROTEIN KINASE 25

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  27
GLY A  32
VAL A  34
ALA A  47
MET A  95
SER A 102
ASN A 145
LEU A 147
ASP A 158
 J60  A1294 ( 4.1A)
None
J60  A1294 ( 4.9A)
J60  A1294 (-3.3A)
J60  A1294 ( 3.8A)
None
None
J60  A1294 (-4.8A)
J60  A1294 ( 4.6A)
 0.74A 3eygA-2xikA:
20.9		 3eygA-2xikA:
32.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z7r RIBOSOMAL PROTEIN S6
KINASE ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase) 		10 LEU A  68
GLY A  69
GLY A  71
GLY A  74
VAL A  76
ALA A  92
LYS A  94
ASN A 192
LEU A 194
ASP A 205
 STU  A   1 (-3.8A)
STU  A   1 (-3.3A)
STU  A   1 ( 4.1A)
None
None
STU  A   1 (-3.3A)
STU  A   1 (-2.8A)
STU  A   1 (-4.3A)
STU  A   1 (-4.6A)
STU  A   1 ( 3.8A)
 0.69A 3eygA-2z7rA:
13.6		 3eygA-2z7rA:
27.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A1002
GLY A1003
GLY A1005
GLY A1008
VAL A1010
ALA A1028
MET A1076
ASN A1137
ASP A1150
 S91  A   1 ( 4.1A)
S91  A   1 ( 3.9A)
None
None
S91  A   1 ( 4.9A)
S91  A   1 (-3.2A)
S91  A   1 ( 4.9A)
None
None
 0.86A 3eygA-2z8cA:
31.4		 3eygA-2z8cA:
35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A1002
GLY A1003
GLY A1005
GLY A1008
VAL A1010
LYS A1030
MET A1076
ASN A1137
ASP A1150
 S91  A   1 ( 4.1A)
S91  A   1 ( 3.9A)
None
None
S91  A   1 ( 4.9A)
S91  A   1 ( 4.2A)
S91  A   1 ( 4.9A)
None
None
 1.01A 3eygA-2z8cA:
31.4		 3eygA-2z8cA:
35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 GLY A 207
VAL A 209
ALA A 220
LYS A 222
SER A 273
ASN A 319
LEU A 321
ASP A 332
 None
 0.70A 3eygA-3d7uA:
32.2		 3eygA-3d7uA:
36.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f2a PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE PIM-1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  44
GLY A  45
GLY A  50
VAL A  52
ALA A  65
LYS A  67
ASN A 172
LEU A 174
ASP A 186
 985  A   1 (-4.1A)
985  A   1 ( 3.9A)
None
985  A   1 (-4.5A)
985  A   1 (-3.5A)
985  A   1 ( 2.8A)
985  A   1 (-4.6A)
985  A   1 (-4.8A)
985  A   1 ( 4.0A)
 0.75A 3eygA-3f2aA:
18.5		 3eygA-3f2aA:
24.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fme DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  59
GLY A  60
GLY A  62
GLY A  65
VAL A  67
ALA A  80
MET A 129
SER A 135
LEU A 186
 STU  A   1 (-3.8A)
STU  A   1 (-3.5A)
None
None
None
STU  A   1 (-3.4A)
STU  A   1 ( 3.8A)
STU  A   1 (-3.2A)
STU  A   1 (-4.4A)
 0.62A 3eygA-3fmeA:
16.6		 3eygA-3fmeA:
28.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fme DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 6

(Homo sapiens) 		PF00069
(Pkinase) 		10 LEU A  59
GLY A  60
GLY A  65
VAL A  67
ALA A  80
LYS A  82
MET A 129
SER A 135
ASN A 184
LEU A 186
 STU  A   1 (-3.8A)
STU  A   1 (-3.5A)
None
None
STU  A   1 (-3.4A)
STU  A   1 ( 4.2A)
STU  A   1 ( 3.8A)
STU  A   1 (-3.2A)
STU  A   1 ( 4.9A)
STU  A   1 (-4.4A)
 0.69A 3eygA-3fmeA:
16.6		 3eygA-3fmeA:
28.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g2f BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-2

(Homo sapiens) 		PF00069
(Pkinase) 		10 GLY A 210
GLY A 212
GLY A 215
VAL A 217
ALA A 228
LYS A 230
MET A 279
SER A 286
ASN A 338
LEU A 340
 ADP  A 900 (-3.4A)
ADP  A 900 (-3.0A)
ADP  A 900 (-3.7A)
ADP  A 900 (-4.3A)
ADP  A 900 (-3.4A)
ADP  A 900 (-2.8A)
ADP  A 900 (-3.6A)
ADP  A 900 (-3.6A)
MG  A 901 ( 2.8A)
ADP  A 900 (-4.6A)
 0.75A 3eygA-3g2fA:
27.8		 3eygA-3g2fA:
27.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g2f BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-2

(Homo sapiens) 		PF00069
(Pkinase) 		10 GLY A 210
GLY A 212
GLY A 215
VAL A 217
LYS A 230
MET A 279
SER A 286
ASN A 338
LEU A 340
ASP A 351
 ADP  A 900 (-3.4A)
ADP  A 900 (-3.0A)
ADP  A 900 (-3.7A)
ADP  A 900 (-4.3A)
ADP  A 900 (-2.8A)
ADP  A 900 (-3.6A)
ADP  A 900 (-3.6A)
MG  A 901 ( 2.8A)
ADP  A 900 (-4.6A)
ADP  A 900 ( 2.7A)
 0.88A 3eygA-3g2fA:
27.8		 3eygA-3g2fA:
27.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3

(Toxoplasma
gondii) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		9 LEU A  82
GLY A  83
GLY A  88
VAL A  90
ALA A 103
LYS A 105
ASN A 204
LEU A 206
ASP A 220
 J60  A 540 (-3.8A)
J60  A 540 ( 4.3A)
GOL  A 544 (-3.4A)
None
J60  A 540 (-3.6A)
GOL  A   1 (-2.7A)
GOL  A 542 ( 4.8A)
GOL  A 542 ( 4.6A)
J60  A 540 ( 3.6A)
 0.74A 3eygA-3hztA:
19.4		 3eygA-3hztA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3

(Toxoplasma
gondii) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		9 LEU A  82
GLY A  83
GLY A  88
VAL A  90
ALA A 103
LYS A 105
MET A 153
ASN A 204
ASP A 220
 J60  A 540 (-3.8A)
J60  A 540 ( 4.3A)
GOL  A 544 (-3.4A)
None
J60  A 540 (-3.6A)
GOL  A   1 (-2.7A)
GOL  A   1 ( 3.0A)
GOL  A 542 ( 4.8A)
J60  A 540 ( 3.6A)
 0.51A 3eygA-3hztA:
19.4		 3eygA-3hztA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3igo CALMODULIN-DOMAIN
PROTEIN KINASE 1

(Cryptosporidium
parvum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		8 LEU A  82
GLY A  83
GLY A  85
GLY A  88
VAL A  90
ALA A 103
LYS A 105
LEU A 205
 ANP  A 610 ( 4.5A)
ANP  A 610 (-3.5A)
ANP  A 610 (-2.9A)
ANP  A 610 (-4.5A)
ANP  A 610 (-3.9A)
ANP  A 610 ( 3.7A)
ANP  A 610 (-2.8A)
None
 0.64A 3eygA-3igoA:
19.5		 3eygA-3igoA:
22.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3kex RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 696
GLY A 699
GLY A 702
VAL A 704
LYS A 723
SER A 775
ASN A 820
LEU A 822
ASP A 833
 ANP  A   1 (-4.4A)
ANP  A   1 (-2.8A)
None
ANP  A   1 (-3.9A)
ANP  A   1 (-3.4A)
None
ANP  A   1 ( 2.6A)
ANP  A   1 (-4.7A)
MG  A1001 ( 3.1A)
 0.87A 3eygA-3kexA:
28.1		 3eygA-3kexA:
30.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3llt SERINE/THREONINE
KINASE-1, PFLAMMER

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		9 GLY A 559
GLY A 561
GLY A 564
VAL A 566
ALA A 579
LYS A 581
SER A 636
ASN A 682
LEU A 684
 ANP  A 877 (-3.8A)
ANP  A 877 (-3.3A)
ANP  A 877 (-3.9A)
ANP  A 877 (-4.1A)
ANP  A 877 ( 3.7A)
ANP  A 877 (-2.7A)
None
ANP  A 877 ( 4.8A)
None
 0.89A 3eygA-3lltA:
8.9		 3eygA-3lltA:
27.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdy BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-1B

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF08515
(TGF_beta_GS) 		9 GLY A 211
GLY A 216
VAL A 218
ALA A 229
LYS A 231
SER A 286
ASN A 337
LEU A 339
ASP A 350
 LDN  A   1 ( 4.7A)
None
LDN  A   1 ( 4.8A)
LDN  A   1 (-3.6A)
None
None
LDN  A   1 (-4.3A)
LDN  A   1 (-4.5A)
LDN  A   1 (-3.9A)
 0.61A 3eygA-3mdyA:
28.4		 3eygA-3mdyA:
28.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mvj CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase) 		11 LEU A  49
GLY A  50
GLY A  52
GLY A  55
VAL A  57
ALA A  70
LYS A  72
MET A 120
ASN A 171
LEU A 173
ASP A 184
 XFE  A 351 (-4.2A)
XFE  A 351 ( 4.0A)
None
None
XFE  A 351 ( 4.5A)
XFE  A 351 (-3.2A)
None
XFE  A 351 ( 4.0A)
None
XFE  A 351 (-4.6A)
None
 0.69A 3eygA-3mvjA:
24.0		 3eygA-3mvjA:
22.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3pp0 RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 726
GLY A 727
GLY A 732
VAL A 734
ALA A 751
LYS A 753
ASN A 850
LEU A 852
ASP A 863
 03Q  A   1 (-3.8A)
None
None
03Q  A   1 (-4.5A)
03Q  A   1 (-3.1A)
03Q  A   1 (-4.7A)
03Q  A   1 (-4.2A)
03Q  A   1 (-4.4A)
03Q  A   1 (-4.0A)
 0.47A 3eygA-3pp0A:
33.2		 3eygA-3pp0A:
31.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q4t ACTIVIN RECEPTOR
TYPE-2A

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A 201
GLY A 204
VAL A 206
ALA A 217
SER A 274
ASN A 327
LEU A 329
ASP A 340
 None
None
TAK  A   2 ( 4.9A)
TAK  A   2 (-3.5A)
None
None
TAK  A   2 (-4.6A)
None
 0.68A 3eygA-3q4tA:
27.8		 3eygA-3q4tA:
24.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfv CDC42BPB PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  83
GLY A  85
GLY A  88
VAL A  90
ALA A 103
LYS A 105
ASN A 205
LEU A 207
ASP A 218
 NM7  A 416 (-3.0A)
None
None
NM7  A 416 (-3.7A)
NM7  A 416 ( 3.7A)
EDO  A 417 (-3.5A)
None
NM7  A 416 ( 4.2A)
EDO  A 417 (-3.7A)
 0.79A 3eygA-3qfvA:
22.6		 3eygA-3qfvA:
21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfv CDC42BPB PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  83
GLY A  85
GLY A  88
VAL A  90
ALA A 103
LYS A 105
MET A 153
ASN A 205
LEU A 207
 NM7  A 416 (-3.0A)
None
None
NM7  A 416 (-3.7A)
NM7  A 416 ( 3.7A)
EDO  A 417 (-3.5A)
NM7  A 416 (-3.6A)
None
NM7  A 416 ( 4.2A)
 0.78A 3eygA-3qfvA:
22.6		 3eygA-3qfvA:
21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		11 LEU A  50
GLY A  51
GLY A  53
GLY A  56
VAL A  58
ALA A  71
LYS A  73
MET A 118
ASN A 171
LEU A 173
ASP A 187
 I85  A 350 (-3.7A)
I85  A 350 (-3.5A)
I85  A 350 (-3.1A)
None
I85  A 350 (-4.9A)
I85  A 350 (-3.3A)
I85  A 350 (-2.8A)
I85  A 350 ( 3.9A)
I85  A 350 (-4.4A)
None
I85  A 350 (-3.3A)
 0.85A 3eygA-3sheA:
20.5		 3eygA-3sheA:
25.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 484
GLY A 485
GLY A 487
GLY A 490
VAL A 492
ALA A 512
LYS A 514
LEU A 630
 07J  A   1 ( 4.3A)
07J  A   1 ( 4.9A)
None
None
07J  A   1 (-4.0A)
07J  A   1 (-3.5A)
07J  A   1 (-4.5A)
07J  A   1 ( 4.4A)
 0.50A 3eygA-3tt0A:
28.1		 3eygA-3tt0A:
30.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3txo PROTEIN KINASE C ETA
TYPE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		9 LEU A 361
GLY A 362
GLY A 367
VAL A 369
ALA A 382
LYS A 384
MET A 433
ASN A 484
LEU A 486
 07U  A   1 ( 4.8A)
07U  A   1 ( 4.2A)
None
07U  A   1 (-4.8A)
07U  A   1 (-3.3A)
07U  A   1 (-3.0A)
07U  A   1 ( 4.3A)
None
07U  A   1 (-4.3A)
 0.75A 3eygA-3txoA:
14.9		 3eygA-3txoA:
25.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3txo PROTEIN KINASE C ETA
TYPE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		9 LEU A 361
GLY A 362
GLY A 367
VAL A 369
LYS A 384
MET A 433
ASN A 484
LEU A 486
ASP A 497
 07U  A   1 ( 4.8A)
07U  A   1 ( 4.2A)
None
07U  A   1 (-4.8A)
07U  A   1 (-3.0A)
07U  A   1 ( 4.3A)
None
07U  A   1 (-4.3A)
07U  A   1 (-3.6A)
 0.87A 3eygA-3txoA:
14.9		 3eygA-3txoA:
25.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wig DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  75
GLY A  76
GLY A  78
VAL A  83
ALA A  96
LYS A  98
MET A 144
LEU A 198
 ANP  A 401 (-3.8A)
ANP  A 401 ( 3.7A)
ANP  A 401 (-3.3A)
ANP  A 401 ( 4.3A)
ANP  A 401 (-3.2A)
ANP  A 401 (-2.7A)
CHU  A 403 (-3.8A)
ANP  A 401 (-4.8A)
 0.67A 3eygA-3wigA:
22.6		 3eygA-3wigA:
26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wig DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		8 LEU A  75
GLY A  76
GLY A  78
VAL A  83
ALA A  96
MET A 144
SER A 151
LEU A 198
 ANP  A 401 (-3.8A)
ANP  A 401 ( 3.7A)
ANP  A 401 (-3.3A)
ANP  A 401 ( 4.3A)
ANP  A 401 (-3.2A)
CHU  A 403 (-3.8A)
ANP  A 401 (-3.3A)
ANP  A 401 (-4.8A)
 0.66A 3eygA-3wigA:
22.6		 3eygA-3wigA:
26.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aw2 SERINE/THREONINE-PRO
TEIN KINASE MRCK
ALPHA

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		8 GLY A  84
VAL A  91
ALA A 104
LYS A 106
MET A 154
ASN A 206
LEU A 208
ASP A 219
 None
None
EDO  A1420 (-3.4A)
EDO  A1419 (-3.3A)
None
None
EDO  A1420 ( 4.8A)
None
 0.70A 3eygA-4aw2A:
22.8		 3eygA-4aw2A:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cfh 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		10 LEU A  22
GLY A  23
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  93
ASN A 144
LEU A 146
ASP A 157
 STU  A1550 (-4.3A)
STU  A1550 (-3.1A)
None
None
STU  A1550 (-3.1A)
STU  A1550 (-3.6A)
STU  A1550 (-3.7A)
STU  A1550 (-4.3A)
STU  A1550 (-4.3A)
STU  A1550 (-3.6A)
 0.93A 3eygA-4cfhA:
26.0		 3eygA-4cfhA:
22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		8 LEU A 663
GLY A 666
GLY A 669
VAL A 671
ALA A 684
MET A 737
ASN A 787
LEU A 789
 AGS  A1985 (-4.2A)
AGS  A1985 (-2.9A)
AGS  A1985 (-4.1A)
AGS  A1985 (-4.6A)
AGS  A1985 (-3.5A)
AGS  A1985 (-4.2A)
MG  A1986 ( 3.2A)
AGS  A1985 (-4.8A)
 0.61A 3eygA-4crsA:
18.1		 3eygA-4crsA:
25.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		8 LEU A 663
GLY A 669
VAL A 671
ALA A 684
LYS A 686
MET A 737
ASN A 787
LEU A 789
 AGS  A1985 (-4.2A)
AGS  A1985 (-4.1A)
AGS  A1985 (-4.6A)
AGS  A1985 (-3.5A)
AGS  A1985 (-3.0A)
AGS  A1985 (-4.2A)
MG  A1986 ( 3.2A)
AGS  A1985 (-4.8A)
 0.64A 3eygA-4crsA:
18.1		 3eygA-4crsA:
25.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  15
GLY A  16
VAL A  23
ALA A  36
LYS A  38
MET A  86
SER A  93
ASN A 140
ASP A 157
 BX7  A 401 (-3.9A)
BX7  A 401 ( 3.8A)
BX7  A 401 ( 4.6A)
BX7  A 401 (-3.4A)
BX7  A 401 (-3.5A)
BX7  A 401 (-3.7A)
BX7  A 401 ( 4.7A)
None
BX7  A 401 (-3.6A)
 0.83A 3eygA-4euuA:
16.7		 3eygA-4euuA:
26.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4fg8 CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE 1

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  26
GLY A  27
GLY A  29
VAL A  34
ALA A  47
LYS A  49
MET A  95
ASN A 146
LEU A 148
 ATP  A 401 (-3.8A)
ATP  A 401 ( 3.7A)
ATP  A 401 (-3.2A)
ATP  A 401 (-4.1A)
ATP  A 401 (-3.6A)
ATP  A 401 (-3.0A)
ATP  A 401 ( 4.3A)
ATP  A 401 (-3.4A)
ATP  A 401 (-4.6A)
 0.89A 3eygA-4fg8A:
22.8		 3eygA-4fg8A:
30.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fl3 TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 377
GLY A 378
GLY A 380
GLY A 383
VAL A 385
ALA A 400
LYS A 402
MET A 448
 ANP  A 701 ( 4.6A)
ANP  A 701 ( 4.0A)
ANP  A 701 (-3.5A)
None
ANP  A 701 (-4.1A)
ANP  A 701 (-3.3A)
ANP  A 701 (-2.7A)
ANP  A 701 ( 3.7A)
 0.47A 3eygA-4fl3A:
28.3		 3eygA-4fl3A:
23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fl3 TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		8 LEU A 377
GLY A 378
GLY A 380
GLY A 383
VAL A 385
ALA A 400
MET A 448
LEU A 501
 ANP  A 701 ( 4.6A)
ANP  A 701 ( 4.0A)
ANP  A 701 (-3.5A)
None
ANP  A 701 (-4.1A)
ANP  A 701 (-3.3A)
ANP  A 701 ( 3.7A)
ANP  A 701 (-4.5A)
 0.58A 3eygA-4fl3A:
28.3		 3eygA-4fl3A:
23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		9 GLY A 409
GLY A 414
VAL A 416
ALA A 429
LYS A 431
MET A 471
ASN A 522
LEU A 524
ASP A 536
 0WB  A 701 ( 4.4A)
None
0WB  A 701 (-4.4A)
0WB  A 701 (-3.3A)
0WB  A 701 (-3.0A)
0WB  A 701 (-3.9A)
0WB  A 701 (-4.1A)
0WB  A 701 (-4.3A)
0WB  A 701 (-3.1A)
 0.81A 3eygA-4g3fA:
25.1		 3eygA-4g3fA:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g3f NF-KAPPA-BETA-INDUCI
NG KINASE

(Mus musculus) 		PF00069
(Pkinase) 		9 GLY A 409
GLY A 414
VAL A 416
ALA A 429
LYS A 431
SER A 478
ASN A 522
LEU A 524
ASP A 536
 0WB  A 701 ( 4.4A)
None
0WB  A 701 (-4.4A)
0WB  A 701 (-3.3A)
0WB  A 701 (-3.0A)
0WB  A 701 ( 4.4A)
0WB  A 701 (-4.1A)
0WB  A 701 (-4.3A)
0WB  A 701 (-3.1A)
 0.67A 3eygA-4g3fA:
25.1		 3eygA-4g3fA:
23.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4gl9 TYROSINE-PROTEIN
KINASE

(Mus musculus) 		PF07714
(Pkinase_Tyr) 		12 LEU A 855
GLY A 856
GLY A 858
GLY A 861
VAL A 863
ALA A 880
LYS A 882
MET A 929
SER A 936
ASN A 981
LEU A 983
ASP A 994
 IZA  A2001 (-3.7A)
IZA  A2001 ( 4.9A)
IZA  A2001 ( 3.7A)
None
None
IZA  A2001 (-3.4A)
IZA  A2001 ( 4.7A)
IZA  A2001 (-4.4A)
None
IZA  A2001 ( 4.7A)
IZA  A2001 ( 4.7A)
IZA  A2001 ( 4.5A)
 0.68A 3eygA-4gl9A:
27.3		 3eygA-4gl9A:
54.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hvi TYROSINE-PROTEIN
KINASE JAK3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 LEU A 828
GLY A 829
GLY A 831
GLY A 834
VAL A 836
ALA A 853
LYS A 855
MET A 902
ASN A 954
LEU A 956
 19S  A1201 (-3.9A)
19S  A1201 (-3.7A)
19S  A1201 ( 4.3A)
19S  A1201 ( 4.9A)
19S  A1201 (-4.4A)
19S  A1201 (-3.3A)
19S  A1201 (-3.5A)
19S  A1201 (-3.6A)
None
19S  A1201 (-4.5A)
 0.59A 3eygA-4hviA:
39.2		 3eygA-4hviA:
48.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzs ACTIVATED CDC42
KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14604
(SH3_9) 		9 LEU A 132
GLY A 133
GLY A 135
GLY A 138
VAL A 140
ALA A 156
LYS A 158
SER A 212
LEU A 259
 None
 0.80A 3eygA-4hzsA:
27.1		 3eygA-4hzsA:
31.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hzs ACTIVATED CDC42
KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14604
(SH3_9) 		9 LEU A 132
GLY A 135
GLY A 138
VAL A 140
ALA A 156
LYS A 158
SER A 212
ASN A 257
LEU A 259
 None
 0.97A 3eygA-4hzsA:
27.1		 3eygA-4hzsA:
31.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4id7 ACTIVATED CDC42
KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 132
GLY A 133
GLY A 135
GLY A 138
VAL A 140
ALA A 156
SER A 212
LEU A 259
 1G0  A 401 ( 4.5A)
1G0  A 401 ( 4.2A)
None
None
1G0  A 401 (-4.4A)
1G0  A 401 (-3.6A)
1G0  A 401 ( 4.3A)
1G0  A 401 (-4.6A)
 0.59A 3eygA-4id7A:
33.7		 3eygA-4id7A:
36.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4id7 ACTIVATED CDC42
KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 132
GLY A 133
GLY A 138
VAL A 140
ALA A 156
LYS A 158
SER A 212
LEU A 259
 1G0  A 401 ( 4.5A)
1G0  A 401 ( 4.2A)
None
1G0  A 401 (-4.4A)
1G0  A 401 (-3.6A)
1G0  A 401 (-3.7A)
1G0  A 401 ( 4.3A)
1G0  A 401 (-4.6A)
 0.66A 3eygA-4id7A:
33.7		 3eygA-4id7A:
36.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A 406
GLY A 407
GLY A 409
GLY A 412
VAL A 414
ALA A 427
LYS A 429
SER A 476
ASN A 520
 T28  A 701 (-3.8A)
T28  A 701 ( 3.6A)
T28  A 701 ( 3.0A)
None
T28  A 701 (-4.7A)
T28  A 701 (-3.0A)
T28  A 701 ( 3.8A)
T28  A 701 (-3.8A)
T28  A 701 ( 4.9A)
 0.75A 3eygA-4idtA:
2.5		 3eygA-4idtA:
27.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4idt MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 14

(Homo sapiens) 		PF00069
(Pkinase) 		11 LEU A 406
GLY A 407
GLY A 412
VAL A 414
ALA A 427
LYS A 429
MET A 469
SER A 476
ASN A 520
LEU A 522
ASP A 534
 T28  A 701 (-3.8A)
T28  A 701 ( 3.6A)
None
T28  A 701 (-4.7A)
T28  A 701 (-3.0A)
T28  A 701 ( 3.8A)
T28  A 701 (-2.6A)
T28  A 701 (-3.8A)
T28  A 701 ( 4.9A)
T28  A 701 (-3.9A)
T28  A 701 ( 3.4A)
 0.70A 3eygA-4idtA:
2.5		 3eygA-4idtA:
27.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k11 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		9 LEU A 273
GLY A 274
GLY A 276
GLY A 279
VAL A 281
ALA A 293
LYS A 295
SER A 345
LEU A 393
 0J9  A 601 (-4.0A)
0J9  A 601 ( 4.0A)
None
None
0J9  A 601 (-4.4A)
0J9  A 601 (-3.3A)
0J9  A 601 ( 4.7A)
0J9  A 601 (-4.5A)
0J9  A 601 (-4.5A)
 0.78A 3eygA-4k11A:
28.6		 3eygA-4k11A:
27.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k11 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		9 LEU A 273
GLY A 274
GLY A 279
VAL A 281
ALA A 293
LYS A 295
SER A 345
ASN A 391
LEU A 393
 0J9  A 601 (-4.0A)
0J9  A 601 ( 4.0A)
None
0J9  A 601 (-4.4A)
0J9  A 601 (-3.3A)
0J9  A 601 ( 4.7A)
0J9  A 601 (-4.5A)
None
0J9  A 601 (-4.5A)
 0.82A 3eygA-4k11A:
28.6		 3eygA-4k11A:
27.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 LEU A 478
GLY A 479
GLY A 484
VAL A 486
ALA A 506
LYS A 508
ASN A 622
LEU A 624
 ACP  A 801 (-3.8A)
ACP  A 801 (-3.4A)
ACP  A 801 (-3.6A)
ACP  A 801 (-4.2A)
ACP  A 801 (-3.3A)
ACP  A 801 (-2.7A)
MG  A 802 ( 2.4A)
ACP  A 801 (-4.4A)
 0.60A 3eygA-4k33A:
34.2		 3eygA-4k33A:
33.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ks8 SERINE/THREONINE-PRO
TEIN KINASE PAK 6

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A 414
GLY A 416
GLY A 419
VAL A 421
ALA A 434
LYS A 436
MET A 481
LEU A 533
 B49  A 701 ( 4.3A)
None
None
None
B49  A 701 (-3.2A)
None
B49  A 701 (-3.4A)
B49  A 701 (-4.5A)
 0.60A 3eygA-4ks8A:
26.7		 3eygA-4ks8A:
26.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l52 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 7,
TGF-BETA-ACTIVATED
KINASE 1 AND
MAP3K7-BINDING
PROTEIN 1 CHIMERA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 GLY A  43
GLY A  45
GLY A  48
VAL A  50
ALA A  61
LYS A  63
MET A 104
SER A 111
ASN A 161
LEU A 163
 1UL  A 501 ( 4.1A)
1UL  A 501 ( 3.7A)
None
1UL  A 501 ( 4.9A)
1UL  A 501 (-3.1A)
None
1UL  A 501 (-3.6A)
None
None
1UL  A 501 (-4.3A)
 0.76A 3eygA-4l52A:
26.6		 3eygA-4l52A:
27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l52 MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 7,
TGF-BETA-ACTIVATED
KINASE 1 AND
MAP3K7-BINDING
PROTEIN 1 CHIMERA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 GLY A  43
GLY A  48
VAL A  50
ALA A  61
SER A 111
ASN A 161
LEU A 163
ASP A 175
 1UL  A 501 ( 4.1A)
None
1UL  A 501 ( 4.9A)
1UL  A 501 (-3.1A)
None
None
1UL  A 501 (-4.3A)
1UL  A 501 (-4.2A)
 0.70A 3eygA-4l52A:
26.6		 3eygA-4l52A:
27.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4o27 SERINE/THREONINE-PRO
TEIN KINASE 24

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY B  31
GLY B  33
GLY B  36
VAL B  38
ALA B  51
LYS B  53
MET B  99
LEU B 151
 ADP  B 500 ( 3.8A)
ADP  B 500 (-3.3A)
None
ADP  B 500 (-4.5A)
ADP  B 500 (-3.3A)
ADP  B 500 (-3.1A)
ADP  B 500 ( 4.1A)
ADP  B 500 (-4.7A)
 0.60A 3eygA-4o27B:
20.0		 3eygA-4o27B:
32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4o27 SERINE/THREONINE-PRO
TEIN KINASE 24

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY B  31
GLY B  33
GLY B  36
VAL B  38
ALA B  51
LYS B  53
MET B  99
SER B 106
 ADP  B 500 ( 3.8A)
ADP  B 500 (-3.3A)
None
ADP  B 500 (-4.5A)
ADP  B 500 (-3.3A)
ADP  B 500 (-3.1A)
ADP  B 500 ( 4.1A)
ADP  B 500 (-3.4A)
 0.61A 3eygA-4o27B:
20.0		 3eygA-4o27B:
32.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 LEU A 903
GLY A 904
GLY A 906
GLY A 909
VAL A 911
ALA A 928
MET A 978
SER A 985
ASN A1028
LEU A1030
 2TT  A1202 (-3.5A)
2TT  A1202 ( 4.2A)
2TT  A1202 ( 3.8A)
None
2TT  A1202 (-4.5A)
2TT  A1202 ( 3.9A)
2TT  A1202 ( 4.4A)
None
2TT  A1202 (-4.5A)
2TT  A1202 (-4.4A)
 0.66A 3eygA-4oliA:
38.5		 3eygA-4oliA:
29.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		9 LEU A 903
GLY A 904
GLY A 906
GLY A 909
VAL A 911
SER A 985
ASN A1028
LEU A1030
ASP A1041
 2TT  A1202 (-3.5A)
2TT  A1202 ( 4.2A)
2TT  A1202 ( 3.8A)
None
2TT  A1202 (-4.5A)
None
2TT  A1202 (-4.5A)
2TT  A1202 (-4.4A)
2TT  A1202 (-4.6A)
 0.81A 3eygA-4oliA:
38.5		 3eygA-4oliA:
29.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oli NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		10 LEU A 903
GLY A 904
GLY A 906
VAL A 911
ALA A 928
LYS A 930
MET A 978
SER A 985
ASN A1028
LEU A1030
 2TT  A1202 (-3.5A)
2TT  A1202 ( 4.2A)
2TT  A1202 ( 3.8A)
2TT  A1202 (-4.5A)
2TT  A1202 ( 3.9A)
None
2TT  A1202 ( 4.4A)
None
2TT  A1202 (-4.5A)
2TT  A1202 (-4.4A)
 0.77A 3eygA-4oliA:
38.5		 3eygA-4oliA:
29.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rew 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 GLY A  25
GLY A  27
GLY A  30
ALA A  45
LYS A  47
MET A  95
ASN A 146
LEU A 148
ASP A 159
 STU  A 601 (-3.5A)
STU  A 601 (-3.4A)
None
STU  A 601 (-3.2A)
STU  A 601 ( 3.7A)
STU  A 601 (-4.3A)
STU  A 601 (-4.2A)
STU  A 601 (-4.2A)
STU  A 601 (-3.7A)
 0.85A 3eygA-4rewA:
25.6		 3eygA-4rewA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rew 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-1

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		10 LEU A  24
GLY A  25
GLY A  30
VAL A  32
ALA A  45
LYS A  47
MET A  95
ASN A 146
LEU A 148
ASP A 159
 STU  A 601 (-3.7A)
STU  A 601 (-3.5A)
None
STU  A 601 ( 4.8A)
STU  A 601 (-3.2A)
STU  A 601 ( 3.7A)
STU  A 601 (-4.3A)
STU  A 601 (-4.2A)
STU  A 601 (-4.2A)
STU  A 601 (-3.7A)
 0.66A 3eygA-4rewA:
25.6		 3eygA-4rewA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wb7 DNAJ HOMOLOG
SUBFAMILY B MEMBER
1,CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA

(Homo sapiens) 		PF00069
(Pkinase)
PF00226
(DnaJ) 		11 LEU A 104
GLY A 105
GLY A 107
GLY A 110
VAL A 112
ALA A 125
LYS A 127
MET A 175
ASN A 226
LEU A 228
ASP A 239
 ATP  A 501 ( 4.3A)
ATP  A 501 (-3.5A)
ATP  A 501 (-3.2A)
ATP  A 501 (-3.8A)
ATP  A 501 (-4.0A)
ATP  A 501 (-3.4A)
ATP  A 501 (-2.6A)
ATP  A 501 (-3.6A)
ZN  A 502 ( 2.5A)
ATP  A 501 (-4.5A)
ZN  A 503 (-1.9A)
 0.64A 3eygA-4wb7A:
24.2		 3eygA-4wb7A:
23.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ysj CALMODULIN-LIKE
DOMAIN PROTEIN
KINASE

(Eimeria tenella) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		8 LEU A  34
GLY A  35
GLY A  37
VAL A  42
ALA A  55
LYS A  57
ASN A 156
LEU A 158
 ADP  A 506 ( 3.8A)
ADP  A 506 (-3.5A)
ADP  A 506 (-2.8A)
ADP  A 506 (-4.3A)
ADP  A 506 (-3.3A)
ADP  A 506 (-2.4A)
MG  A 505 ( 2.7A)
ADP  A 506 (-4.7A)
 0.68A 3eygA-4ysjA:
26.5		 3eygA-4ysjA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  32
GLY A  34
GLY A  37
VAL A  39
LYS A  54
SER A 112
ASN A 158
LEU A 160
ASP A 171
 GLY  A  32 ( 0.0A)
GLY  A  34 ( 0.0A)
GLY  A  37 ( 0.0A)
VAL  A  39 (-0.6A)
LYS  A  54 ( 0.0A)
SER  A 112 (-0.0A)
ASN  A 158 ( 0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.94A 3eygA-5d7aA:
24.2		 3eygA-5d7aA:
27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d7a TRAF2 AND
NCK-INTERACTING
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  32
GLY A  37
VAL A  39
ALA A  52
LYS A  54
SER A 112
ASN A 158
LEU A 160
ASP A 171
 GLY  A  32 ( 0.0A)
GLY  A  37 ( 0.0A)
VAL  A  39 (-0.6A)
ALA  A  52 (-0.0A)
LYS  A  54 ( 0.0A)
SER  A 112 (-0.0A)
ASN  A 158 ( 0.6A)
LEU  A 160 (-0.6A)
ASP  A 171 ( 0.5A)
 0.71A 3eygA-5d7aA:
24.2		 3eygA-5d7aA:
27.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e8y TGF-BETA RECEPTOR
TYPE-2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 GLY A 251
GLY A 253
VAL A 258
ALA A 275
LYS A 277
ASN A 384
LEU A 386
ASP A 397
 STU  A 601 (-2.9A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.0A)
STU  A 601 (-3.1A)
STU  A 601 (-2.4A)
STU  A 601 ( 4.9A)
STU  A 601 (-3.9A)
STU  A 601 (-3.0A)
 0.70A 3eygA-5e8yA:
28.3		 3eygA-5e8yA:
27.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5f1z NON-RECEPTOR
TYROSINE-PROTEIN
KINASE TYK2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		11 LEU A 903
GLY A 904
GLY A 909
VAL A 911
ALA A 928
LYS A 930
MET A 978
SER A 985
ASN A1028
LEU A1030
ASP A1041
 5U3  A1200 (-3.8A)
5U3  A1200 ( 3.7A)
None
5U3  A1200 ( 4.4A)
5U3  A1200 (-3.5A)
None
5U3  A1200 ( 4.0A)
None
5U3  A1200 (-4.7A)
5U3  A1200 (-4.4A)
5U3  A1200 ( 4.9A)
 0.35A 3eygA-5f1zA:
39.2		 3eygA-5f1zA:
57.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hu3 CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE II ALPHA
CHAIN

(Drosophila
melanogaster) 		PF00069
(Pkinase) 		8 LEU A  20
GLY A  21
GLY A  23
VAL A  28
ALA A  41
LYS A  43
ASN A 141
LEU A 143
 ADP  A 301 ( 4.0A)
ADP  A 301 (-3.6A)
ADP  A 301 (-2.8A)
ADP  A 301 (-3.7A)
ADP  A 301 (-3.5A)
ADP  A 301 (-2.7A)
MG  A 302 ( 2.8A)
ADP  A 301 (-4.7A)
 0.66A 3eygA-5hu3A:
27.0		 3eygA-5hu3A:
24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5i3o BMP-2-INDUCIBLE
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase) 		9 LEU A  57
GLY A  60
VAL A  65
ALA A  77
LYS A  79
MET A 130
ASN A 185
LEU A 187
ASP A 198
 IDV  A 401 (-3.8A)
IDV  A 401 (-3.5A)
IDV  A 401 (-4.6A)
IDV  A 401 (-3.6A)
IDV  A 401 ( 4.8A)
IDV  A 401 (-3.4A)
IDV  A 401 (-4.1A)
IDV  A 401 (-4.4A)
IDV  A 401 (-4.0A)
 0.84A 3eygA-5i3oA:
25.5		 3eygA-5i3oA:
26.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		9 LEU A  22
GLY A  23
GLY A  25
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  93
LEU A 146
 STU  A 601 (-4.1A)
STU  A 601 (-3.4A)
STU  A 601 (-3.7A)
992  A 602 ( 3.8A)
STU  A 601 (-4.8A)
STU  A 601 (-3.3A)
STU  A 601 ( 4.4A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.5A)
 0.81A 3eygA-5isoA:
25.6		 3eygA-5isoA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5iso 5'-AMP-ACTIVATED
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA-2

(Homo sapiens) 		PF00069
(Pkinase)
PF16579
(AdenylateSensor) 		10 LEU A  22
GLY A  23
GLY A  25
GLY A  28
VAL A  30
ALA A  43
MET A  93
ASN A 144
LEU A 146
ASP A 157
 STU  A 601 (-4.1A)
STU  A 601 (-3.4A)
STU  A 601 (-3.7A)
992  A 602 ( 3.8A)
STU  A 601 (-4.8A)
STU  A 601 (-3.3A)
STU  A 601 ( 3.9A)
STU  A 601 (-4.3A)
STU  A 601 (-4.5A)
STU  A 601 (-3.5A)
 0.82A 3eygA-5isoA:
25.6		 3eygA-5isoA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3

(Homo sapiens) 		PF00069
(Pkinase) 		9 GLY A  23
GLY A  28
VAL A  30
ALA A  43
LYS A  45
MET A  90
ASN A 141
LEU A 143
ASP A 154
 None
None
6G2  A 901 ( 4.9A)
6G2  A 901 (-3.2A)
6G2  A 901 ( 3.9A)
6G2  A 901 (-3.5A)
None
6G2  A 901 (-4.7A)
6G2  A 901 (-3.4A)
 0.67A 3eygA-5j5tA:
23.0		 3eygA-5j5tA:
25.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kbr SERINE/THREONINE-PRO
TEIN KINASE PAK 1

(Homo sapiens) 		PF00069
(Pkinase) 		8 GLY A 277
GLY A 279
GLY A 282
VAL A 284
ALA A 297
LYS A 299
SER A 351
LEU A 396
 IPW  A 601 ( 3.9A)
None
None
IPW  A 601 (-4.2A)
IPW  A 601 (-3.5A)
IPW  A 601 (-4.5A)
None
IPW  A 601 (-4.5A)
 0.69A 3eygA-5kbrA:
23.5		 3eygA-5kbrA:
26.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u94 SERINE/THREONINE-PRO
TEIN KINASE PKNB

(Mycobacterium
tuberculosis) 		no annotation 8 LEU A  17
GLY A  18
VAL A  25
ALA A  38
LYS A  40
MET A  92
ASN A 143
ASP A 156
 G93  A 301 ( 3.8A)
G93  A 301 ( 3.2A)
G93  A 301 (-3.4A)
G93  A 301 ( 3.7A)
G93  A 301 (-3.0A)
G93  A 301 (-2.7A)
MG  A 310 (-3.2A)
G93  A 301 ( 3.2A)
 0.68A 3eygA-5u94A:
26.8		 3eygA-5u94A:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vil MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE 5

(Homo sapiens) 		no annotation 11 LEU A 686
GLY A 687
GLY A 692
VAL A 694
ALA A 707
LYS A 709
MET A 754
SER A 761
ASN A 808
LEU A 810
ASP A 822
 9E1  A1001 (-3.7A)
9E1  A1001 ( 3.4A)
None
9E1  A1001 ( 4.0A)
9E1  A1001 (-3.5A)
9E1  A1001 (-2.8A)
9E1  A1001 (-2.8A)
9E1  A1001 ( 3.9A)
9E1  A1001 ( 4.0A)
9E1  A1001 (-4.5A)
9E1  A1001 (-3.6A)
 0.69A 3eygA-5vilA:
28.0		 3eygA-5vilA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wno RECEPTOR
TYROSINE-PROTEIN
KINASE LET-23

(Caenorhabditis
elegans) 		no annotation 9 LEU A 891
GLY A 892
GLY A 894
GLY A 897
VAL A 899
ALA A 917
LYS A 919
ASN A1015
LEU A1017
 ANP  A1201 (-4.1A)
ANP  A1201 ( 3.8A)
ANP  A1201 (-2.8A)
None
ANP  A1201 (-4.4A)
ANP  A1201 (-3.3A)
ANP  A1201 (-3.8A)
MG  A1202 ( 2.9A)
ANP  A1201 (-4.7A)
 0.76A 3eygA-5wnoA:
27.1		 3eygA-5wnoA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wno RECEPTOR
TYROSINE-PROTEIN
KINASE LET-23

(Caenorhabditis
elegans) 		no annotation 9 LEU A 891
GLY A 894
GLY A 897
VAL A 899
ALA A 917
LYS A 919
ASN A1015
LEU A1017
ASP A1028
 ANP  A1201 (-4.1A)
ANP  A1201 (-2.8A)
None
ANP  A1201 (-4.4A)
ANP  A1201 (-3.3A)
ANP  A1201 (-3.8A)
MG  A1202 ( 2.9A)
ANP  A1201 (-4.7A)
MG  A1202 ( 3.0A)
 0.86A 3eygA-5wnoA:
27.1		 3eygA-5wnoA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 8 LEU A 366
GLY A 367
VAL A 374
ALA A 388
LYS A 390
MET A 438
ASN A 489
ASP A 502
 EE4  A 701 ( 4.6A)
EE4  A 701 (-3.9A)
EE4  A 701 (-4.4A)
EE4  A 701 (-3.3A)
DMS  A 702 (-3.5A)
EE4  A 701 ( 3.8A)
EE4  A 701 ( 4.9A)
DMS  A 702 ( 3.1A)
 0.53A 3eygA-6c0tA:
18.9		 3eygA-6c0tA:
16.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6c7y TYROSINE-PROTEIN
KINASE JAK1

(Homo sapiens) 		no annotation 11 LEU A 881
GLY A 882
GLY A 884
GLY A 887
VAL A 889
ALA A 906
LYS A 908
MET A 956
SER A 963
ASN A1008
LEU A1010
 ADP  A1201 ( 4.5A)
ADP  A1201 (-3.5A)
ADP  A1201 (-3.3A)
ADP  A1201 (-3.4A)
ADP  A1201 (-4.3A)
ADP  A1201 (-3.4A)
ADP  A1201 (-2.8A)
ADP  A1201 (-4.2A)
ADP  A1201 (-3.3A)
MG  A1202 ( 2.5A)
ADP  A1201 (-4.5A)
 0.63A 3eygA-6c7yA:
30.5		 3eygA-6c7yA:
95.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6c7y TYROSINE-PROTEIN
KINASE JAK1

(Homo sapiens) 		no annotation 11 LEU A 881
GLY A 882
GLY A 884
GLY A 887
VAL A 889
ALA A 906
LYS A 908
SER A 963
ASN A1008
LEU A1010
ASP A1021
 ADP  A1201 ( 4.5A)
ADP  A1201 (-3.5A)
ADP  A1201 (-3.3A)
ADP  A1201 (-3.4A)
ADP  A1201 (-4.3A)
ADP  A1201 (-3.4A)
ADP  A1201 (-2.8A)
ADP  A1201 (-3.3A)
MG  A1202 ( 2.5A)
ADP  A1201 (-4.5A)
MG  A1203 (-1.8A)
 0.72A 3eygA-6c7yA:
30.5		 3eygA-6c7yA:
95.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cth CONCANAVALIN A-LIKE
LECTIN PROTEIN
KINASE FAMILY
PROTEIN

(Theobroma cacao) 		no annotation 8 LEU A 275
GLY A 276
GLY A 281
VAL A 283
ALA A 296
LYS A 298
SER A 350
ASN A 398
 FE7  A 601 (-3.8A)
FE7  A 601 ( 3.7A)
None
FE7  A 601 ( 4.3A)
FE7  A 601 (-3.3A)
FE7  A 601 (-3.6A)
FE7  A 601 (-3.3A)
MG  A 602 ( 4.4A)
 0.71A 3eygA-6cthA:
25.0		 3eygA-6cthA:
16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f3d INTERLEUKIN-1
RECEPTOR-ASSOCIATED
KINASE 4

(Homo sapiens) 		no annotation 8 GLY A 193
GLY A 195
GLY A 198
VAL A 200
ALA A 211
LYS A 213
SER A 269
LEU A 318
 CJT  A 502 ( 3.9A)
None
None
CJT  A 502 ( 4.8A)
CJT  A 502 (-3.4A)
CJT  A 502 (-3.0A)
CJT  A 502 ( 4.3A)
CJT  A 502 (-4.7A)
 0.67A 3eygA-6f3dA:
25.6		 3eygA-6f3dA:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fek PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET

(Homo sapiens) 		no annotation 9 LEU A 730
GLY A 731
GLY A 733
GLY A 736
VAL A 738
ALA A 756
SER A 811
ASN A 879
LEU A 881
 ADN  A1104 ( 4.0A)
ADN  A1104 ( 3.9A)
ADN  A1104 ( 4.0A)
None
ADN  A1104 (-4.4A)
ADN  A1104 (-3.4A)
ADN  A1104 (-3.7A)
None
ADN  A1104 (-4.3A)
 0.63A 3eygA-6fekA:
33.8		 3eygA-6fekA:
15.62